Scholar Rock Holding Corporation (SRRK)
收市後：
- InvestorPlace
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
Investors continue to search for the next big weight loss drug stocks following the success of Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO). So-called GLP-1 receptor agonists represent a fundamental change in weight loss treatment. The active ingredients produce substantially greater weight loss than any other drugs on the market. I’d venture a guess that some investors assume that the best returns have already been had. However, there’s lots of evidence suggesting otherwise. Global obesity
- Insider Monkey
Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks
In this article, we will take a detailed look at Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Paul Tudor Jones and Insiders Love These 5 Stocks. In an interview given to the Palm Beach Civic Association in January 2024, billionaire Paul Tudor Jones said that […]
- InvestorPlace
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
Americans live longer than ever, and a handful of biotech stocks stand at the forefront of longevity’s future. Many misconceive anti-aging stocks as peddling some magic pill that inexplicably makes you live longer — that perception is pure fiction. While many treatments help extend your life if leveraged properly and consistently — namely, diet and exercise — the most compelling longevity stocks address specific age-associated ailments instead. As we age, rapid neurological and physical degenera
